Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly

AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.

BMY
Bristol-Myers Squibb Co
NYSE
49.14
Open 49.21 Prev Close 49.18
High 49.21 Low 49.14
Volume 99 Volume (Avg) 15,585
52 Week High 61.00 52 Week Low 42.38
Market Cap 100B PE Ratio 16.59

Shares Stats

Shares Outstanding2,036,000,000
Shares Float2,032,100,000
Shares Short31,690,000
Insider Holdings9%
Institution Holdings81.80%

About Bristol-Myers Squibb Co

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

General

NameBristol-Myers Squibb Co
TickerBMY
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees34,100

Highlights

Analyst Target52.43
Market Cap100,036,900,000
PE Ratio16.59
PEG Ratio2.26
EBITDA19,217,000,448

Financials

Curr Year EPS Estimate6.54
Next Quarter EPS Estimate1.57
Profit Margin12.57%
Operating Margin29.18
Return on Assets0.09
Return on Equity0.34
Revenue48B
Earnings Per Share2.97
Revenue Per Share23.63
Gross Profit35,135,000,576
Quarterly Revenue Growth0.03

Valuation

Trailing PE16.56
Forward PE8.13
Price/Sales (Trailing 12 Mt.)2.08
Price/Book (Most Recent Quarter)5.40

Dividend

Bristol-Myers Squibb Co pays out a dividend of $2.47 per share, with a dividend yield of 5.03%.

BMY's last dividend payment was made to shareholders on November 3, 2025.

They pay out 0.00% of their earnings out as a dividend.

Recent Dividends

Nov 3, 2025$0.62
Aug 1, 2025$0.62
May 1, 2025$0.62
Feb 3, 2025$0.62
Nov 1, 2024$0.60
Aug 1, 2024$0.60
May 1, 2024$0.60
Feb 1, 2024$0.60
Most Popular

Space forecasters say severe solar storms could hit Earth and trigger auroras

NEW YORK (AP) — Space weather forecasters issued an alert on Tuesday for incoming severe that could produce and temporarily disrupt communications.

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

Trump attacks ABC News correspondent Mary Bruce in angry response to three sharp questions

NEW YORK (AP) — President Donald Trump denounced ABC News' Mary Bruce as a “terrible reporter” Tuesday and threatened the network's license to broadcast after she asked him three sharp questions at the White House.

The Next Biggest Bull Run In Over 50 Years - Ad

Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.

Silver Soars To Record Highs: It's Up 95% In 2025, The Best Year Since 1979

Silver prices surge over 5% as investors rush to secure metal amid tight supplies and global shortage concerns, driving up stocks and mining equities.

California revokes 17,000 driver's licenses. But the state disputes it is over immigration concerns

California plans to revoke 17,000 commercial driver’s licenses given to immigrants after the Trump administration raised concerns about people in the country illegally receiving licenses to drive a semitruck or a bus. But Gov. Gavin Newsom said that isn't the reason.

Legally "Skim" $6,361 Into Your Account? - Ad

A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.

Cathie Wood Bets Big On These Stocks As Bitcoin, Ethereum Crash —Dumps Instagram Rival

On Tuesday, Cathie Wood-led Ark Invest made significant trades, notably increasing its holdings in Bullish (NYSE:BLSH), Coinbase Glo

How Tyson's Chicken Business Will Offset Beef Weakness

Tyson shares rise as pricing catch-up expected to ease cost pressures; chicken strength offsets beef headwinds amid stable feed costs.

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

All 14 victims identified from fiery UPS cargo plane crash in Louisville

LOUISVILLE, Ky. (AP) — A grandfather and his young granddaughter. An electrician with two young children. A woman standing in line at a scrap metal business.

Inside: What's Going on Behind the Scenes in DC? - Ad

Former CIA officer Buck Sexton just met with Trump and VP J.D. Vance - and what he uncovered inside the West Wing is stunning. With ties to Tulsi Gabbard, Mike Johnson, Kash Patel, and more, he's rushing this urgent interview to reveal shocking secrets unfolding behind the scenes right now.

Trump commutes prison sentence for former private equity executive David Gentile

HALLANDALE BEACH, Fla. (AP) — President has commuted the prison sentence of former investment manager David Gentile, who was convicted of defrauding investors — the latest in a Trump has taken in .

Is This Nvidia's Next Big Invention? - Ad

Nvidia helped trigger a historic AI boom that minted 600,000 millionaires in America. It's now working on a new tech that could be even bigger than AI. According to Bank of America, "this [technology] could be the biggest revolution for humanity since discovering fire."

White House's 50-year mortgage proposal has one notable benefit but a number of drawbacks

NEW YORK (AP) — The White House says it is considering backing a 50-year mortgage to help alleviate the home affordability crisis in the country. But the announcement drew immediate criticism from policymakers, social media and economists, who said a 50-year mortgage would do little to resolve other core problems in the housing market, such as a lack of supply and high interest rates.

Trump Hints At Tax Cut, John Bolton Warns Of Peace Prize Ambitions And More: This Week in Politics

Trump hints at major income tax cuts, while political tensions rise over military orders, Russia policy, and government shutdown threats.

The Smart Money Copper Trade - Ad

Only one lines up grade, scale potential, and Quebec power like this. Insider alignment is real. Stepouts are opening new zones. With EVs and grid buildouts rising, this could be the timely copper idea you have been waiting for.

DOJ Greenlights Strikes on Drug Boats, Citing Fentanyl as Potential Chemical Weapon

The DOJ has classified Fentanyl as a potential chemical weapon. This classification has led to the authorization of strikes on drug-smuggling boats.

The Polish 'magicians of glass' who create Christmas baubles for clients worldwide

CZĘSTOCHOWA, Poland (AP) — If you could design a bauble for your own Christmas tree, what would it be — a teddy bear dressed as a ballerina, a hummingbird, or a crimson phoenix?

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

Samsung Hikes Key Chip Prices 60% To Keep Up With AI Boom 'Panic Ordering'

Samsung Electronics (OTC: SSNLF) has hiked prices on key memory chips by up to 60% since September due to high demand and supply shortage.

$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad

Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.

Axon Enterprise: From TASER To AI-Powered Public Safety Platform

Axon Enterprise is executing an interesting transition from hardware vendor to high-margin SaaS and AI platform...

Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad

AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.

Dogecoin Cheers Debut Of ETF That Aims To Multiply Its Returns: 'Much Congrats'

Dogecoin (CRYPTO: DOGE) cheered the launch of a new exchange-traded fund on Wall Street on Thursday that aims to provide leveraged exposure to the popular meme coin

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

Bill Gates' Daughter Phoebe's AI Shopping Assistant Found Collecting Extensive User Data: Report

Phia, co-founded by Phoebe Gates, has been found collecting extensive user data through its browser extension, raising privacy concerns.

Full blackout hits the Dominican Republic as crews scramble to restore power

SANTO DOMINGO, Dominican Republic (AP) — A rare blackout hit the entire on Tuesday, snarling traffic and paralyzing businesses in the country of nearly 11 million people.

The Next Biggest Bull Run In Over 50 Years - Ad

Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.

Peter Schiff Says Bitcoin Buyers Have Only One (Unlikely) Hope To Bail Them Out

Bitcoin's (CRYPTO: BTC) slide through key support levels has brought long-time critic and gold advocate Peter Schiff back into the spotlight—and he's

Cipher Mining Stock Pops As JPMorgan Moves To Overweight

Cipher Mining shares are rising Monday after JPMorgan upgraded the stock to Overweight and raised its price target to $18.

Legally "Skim" $6,361 Into Your Account? - Ad

A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.

Paul Krugman Warns AI Rallies Driven By Rate-Cut Hopes Are 'Dead Cat Bounces' — Says It 'Bears an Unmistakable Resemblance' To The Dot-Com Era

Economist Paul Krugman is drawing sharp parallels between the current state of the AI trade and the final years of the dot-com boom in the 1990s, while warning that investors might be misreading the Federal Reserve's recent signals and actions.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service